parkinson glutathione oxidative ipsc Decreases Parkinsonism‐Induced Ferroptosis and Stress Through the Inhibition of the TRPM2 Channel in Neuronal Cells - Güzel - 2025 - Pharmacology Research & Perspectives Glutathione & Parkinson's: Evidence, Biomarkers,

Springer, pp 269295 Hayashi S, Tanikawa H, Kuramata M, Abe T, Ishikawa S (2020) Domain exchange between Oryza sativa phytochelatin synthases reveals a region that determines responsiveness to arsenic and heavy metals

To date, there is no proven and approved treatment for clinical use in patients with nonalcoholic fatty liver disease with significant efficacy

Taken together, preclinical and clinical studies in neuroblastoma suggest the potential for BSO to enhance L-PAM activity against diseases that use myeloablative dosing of L-PAM and previous investigations with one murine plasmacytoma, 17 and a human MM cell line, 8, 10 demonstrated enhanced activity of L-PAM by BSO

Mol Cell Endocrinol (2008) 286:16979

Realistic expectations and maintenance are essential

510 mg once daily for a short ~1020 day cycle, typically repeated 23 per year